INDUCTION OF INVITRO AND INVIVO ANTITUMOR RESPONSES BY SENSITIZATION OF MICE WITH LIPOSOMES CONTAINING A CRUDE BUTANOL EXTRACT OF LEUKEMIA-CELLS AND TRANSFERRED INTER-MEMBRANOUSLY WITH CELL-SURFACE PROTEINS

被引:22
作者
SHIBATA, R
NOGUCHI, T
SATO, T
AKIYOSHI, K
SUNAMOTO, J
SHIKU, H
NAKAYAMA, E
机构
[1] NAGASAKI UNIV,FAC ENGN,DEPT IND CHEM,NAGASAKI 852,JAPAN
[2] KYOTO UNIV,FAC ENGN,DEPT POLYMER CHEM,KYOTO 606,JAPAN
关键词
D O I
10.1002/ijc.2910480322
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Generation of cytotoxic T lymphocytes (CTL) in vitro and tumor-rejection responses by sensitization of semi-syngeneic mice with tumor-antigen-reconstituted liposomes were investigated. Liposomes were prepared from a crude butanol extract (CBE) of BALBRVD leukemia cells and egg phosphatidylcholine (PC): 1,2-dimyristoylamido-1,2-deoxyphosphatidyl-choline (DDPC) (3:2) or dimyristoylphosphatidylcholine (DMPC) : DDPC (1:4). Inter-membrane protein transfer (IMPT) liposomes were prepared by incubating BALBRVD cells with DMPC : DDPC (1:4) liposomes. Sensitization of male CB6F1 mice with CBE or IMPT liposomes induced a level of cytotoxicity similar to that on sensitization with mitomycin-C(MMC)-treated BALBRVD against BALBRVD target cells after in vitro sensitization with the tumor cells. sensitization with CBE alone resulted in only marginal cytotoxicity. The cytotoxic effector cells induced by either mode of sensitization were CD8+ T-cells whose recognition was K(d)-restricted. No difference in specificity was observed with the different modes of sensitization. Two in vivo immunizations with CBE or with CBE liposomes at a dose of 25-mu-g of protein (equivalent to 2.5 x 10(7) cells) cause moderate inhibition of BALBRVD tumor growth in male CB6F1 mice and immunization with IMPT liposomes at a dose of 1-mu-g of protein result in efficient protection.
引用
收藏
页码:434 / 442
页数:9
相关论文
共 28 条
[1]   LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS [J].
ALLISON, AC ;
GREGORIADIS, G .
NATURE, 1974, 252 (5480) :252-252
[2]  
BAKOUCHE O, 1986, IMMUNOLOGY, V57, P219
[3]   CROSS-PRIMING FOR A SECONDARY CYTOTOXIC RESPONSE TO MINOR H-ANTIGENS WITH H-2 CONGENIC CELLS WHICH DO NOT CROSS-REACT IN CYTOTOXIC ASSAY [J].
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (05) :1283-1288
[4]  
BOUMA SR, 1977, J BIOL CHEM, V252, P6759
[5]  
DUNNICK JK, 1976, CANCER RES, V36, P2385
[6]  
FOLEY EJ, 1953, CANCER RES, V13, P835
[7]  
GOLDSTEIN SAN, 1987, J IMMUNOL, V138, P2034
[8]  
Gross L, 1943, CANCER RES, V3, P326
[9]  
HUESTIS WH, 1986, J BIOL CHEM, V261, P6274
[10]  
JOHNSON JD, 1980, J LAB CLIN MED, V95, P429